Physician

Angelo A Baccala, MD

According to 2025 Medicare claims, Angelo Baccala, MD (NPI: 1811019797) practices urology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY PHYSICIAN GROUP (NPI: 1710208467; TIN: 232700908) and primary practice location at 18103-6224. Baccala is affiliated with the Lehigh Valley Health Network Accountable Care Organization, LLC (ACO ID: A2735), participating under the MSSP model.

Baccala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 5,548 HCPCS/CPT codes, and received $167,998 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 520 prescription claims across 193 beneficiaries totaling $32,857 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 72 claims. Open Payments data shows 45 records totaling $24,375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $86,197 to $32,857. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $171 and ending at $348.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	467	2,122	$172,249
2016	436	2,361	$192,019
2017	447	2,039	$185,983
2018	416	1,807	$210,102
2019	425	2,423	$193,133
2020	520	2,329	$164,988
2021	700	2,778	$241,847
2022	540	3,843	$170,128
2023	431	5,563	$148,663
2024	549	5,548	$167,998

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	1,039	$86,197
2016	245	899	$107,864
2017	196	615	$81,987
2018	141	432	$68,115
2019	117	339	$23,012
2020	115	319	$24,249
2021	134	284	$32,735
2022	124	318	$46,522
2023	146	362	$25,401
2024	193	520	$32,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$426
2016	N/R	50	$2,117
2017	N/R	39	$2,204
2018	N/R	124	$8,248
2019	N/R	155	$10,083
2020	N/R	75	$2,896
2021	N/R	64	$3,107
2022	11	135	$7,293
2023	N/R	113	$4,779
2024	N/R	72	$3,689

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	135	162	$160
76872	Ultrasound scan of pelvic region through rectum	114	122	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	164	193	$78
96372	Injection of drug or substance under skin or into muscle	113	121	$11
81003	Automated urinalysis test	262	387	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	16	1,440	$20,168
Tamsulosin Hcl	Tamsulosin Hcl	254	21,659	$5,785
Dutasteride	Dutasteride	25	2,250	$1,335
Finasteride	Finasteride	65	5,310	$1,052
Solifenacin Succinate	Solifenacin Succinate	18	1,620	$757

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	19	$2,071
A4430	Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each	N	N/R	11	$927
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	28	$600
A5120	Skin barrier, wipes or swabs, each	N	N/R	14	$91

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$24,375	Myriad Genetic Laboratories, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Angelo A. Baccala, MD?

Tedicare shows public-source Medicare data for Angelo A. Baccala, MD (NPI 1811019797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Angelo A. Baccala, MD have ACO affiliation data?

Angelo A. Baccala, MD is shown with ACO affiliation data for Lehigh Valley Health Network Accountable Care Organization, LLC (MSSP, ACO ID A2735).

What billing organization is linked to Angelo A. Baccala, MD?

Angelo A. Baccala, MD is linked to LEHIGH VALLEY PHYSICIAN GROUP (billing NPI 1710208467) in the available physician profile data.

Does Angelo A. Baccala, MD have Open Payments data?

Angelo A. Baccala, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.